Search alternatives:
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
361
-
362
-
363
Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines.
Published 2013“…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC<sub>50</sub> concentration of fenretinide during different time points (24–48–72 hours). …”
-
364
-
365
-
366
Inhibition of RecA-mediated and DNA-dependent ATP hydrolysis by RecX proteins.
Published 2016Subjects: -
367
Inhibition of RecA-mediated ATP hydrolysis by RecX proteins during DNA strand exchange.
Published 2016Subjects: -
368
-
369
-
370
-
371
Loss of hyperrec phenotype in cells expressing RecA D112R upon continuous culture.
Published 2016Subjects: -
372
-
373
-
374
-
375
Positive modulation of mGluR5 decreases spine density in the nucleus accumbens but not in the dorsal striatum.
Published 2016“…<p>(A) Twenty-four hours after systemic administration, CDPPB (5–10 mg/kg, <i>n</i> = 18 animals) decreased dendritic spine density and frequency of small head diameter spines (0.2 μm bin) compared to vehicle control (<i>n</i> = 8) in the nucleus accumbens core. …”
-
376
-
377
-
378
-
379
-
380